Highlights
A collection of news and information related to Cubist Pharmaceuticals Incorporated published by this site and its partners.
Displaying items 1-8 of 8
» View wsbtradio.com items only
-
U.S. RESEARCH ROUNDUP: Microsoft, ICE, Actavis, Boeing
ReutersMay 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Actavis, and Microsoft, on Tuesday. HIGHLIGHTS * Microsoft Corp : Janney, UBS raise price target on stock * Boeing : UBS...Tags: Liberty Media Corporation, Williams Companies Incorporated, Arts and Culture, Petroleum Industry, CME Group Inc.
-
U.S. court ruling favors Cubist in patent case vs Hospira
ReutersMay 20 (Reuters) - A U.S. federal court on Monday ruled in favor of Cubist Pharmaceuticals Inc on the interpretation of patent language in a case involving a generic challenge to its lead drug Cubicin by Hospira Inc. The ruling, in U.S. District Court in...Tags: Stock Market, Hospira, Inc., Patents, Copyrights and Trademarks, NYSE Euronext, Inc., NASDAQ
-
U.S. court ruling favors Cubist in patent case versus Hospira
Reuters(Reuters) - A federal court on Monday ruled in favor of Cubist Pharmaceuticals Inc on the interpretation of patent language in a case involving a generic challenge to its lead drug Cubicin by Hospira Inc . The ruling, in U.S. District Court in Delaware,...Tags: Stock Market, Hospira, Inc., Patents, Copyrights and Trademarks, NYSE Euronext, Inc., Lake Forest
-
Deals of the day -- mergers and acquisitions
ReutersMay 16 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Thursday: ** DDR Corp, owner of shopping centers where big-box retailers are located, said on Wednesday it had agreed to buy from Blackstone Group LP...Tags: BP Plc, Companies and Corporations, Japan, Sweden, Drugs and Medicines
-
Market Chatter-Corporate finance press digest
ReutersMay 16 (Reuters) - The following corporate finance-related stories were reported by media on Thursday: * Dish Network Corp has lined up four banks to finance its $25.5 billion bid for Sprint Nextel Corp, escalating the bidding war against Japanese...Tags: Bain Capital, LLC, Italy, JPMorgan Chase & Co., Singapore, Drugs and Medicines
-
Cubist bid almost $1 bln for Optimer before sale process-sources
ReutersBy Jessica Toonkel NEW YORK, May 15 (Reuters) - Before Optimer Pharmaceuticals Inc even put itself up for sale earlier this year, Cubist Pharmaceuticals Inc offered to buy the antibiotic maker for $20 per share, or nearly $1 billion, two people...Tags: Japan, Diarrhea, AstraZeneca Plc, Thomson Corporation
-
Cubist bid for Optimer before sale process began: sources
ReutersNEW YORK (Reuters) - Before Optimer Pharmaceuticals Inc even put itself up for sale earlier this year, Cubist Pharmaceuticals Inc offered to buy the antibiotic maker for $20 per share, or nearly $1 billion, two people familiar with the matter told Reuters...Tags: Japan, Diarrhea, AstraZeneca Plc, Thomson Corporation
-
U.S. RESEARCH ROUNDUP: Estee Lauder, Actavis, MGM Resorts
ReutersMay 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Estee Lauder and MGM Resorts, on Friday. HIGHLIGHTS * LinkedIn Corp : BMO, JP Morgan, Canaccord Genuity, others raise...Tags: Environmental Issues, HudBay Minerals Incorporated, GP Strategies Corporation, SYSCO Corporation, Semiconductors and Active Components
May 21, 2013
|Story| Reuters
May 20, 2013
|Story| Reuters
May 20, 2013
|Story| Reuters
May 16, 2013
|Story| Reuters
May 15, 2013
|Story| Reuters
May 15, 2013
|Story| Reuters
May 15, 2013
|Story| Reuters
May 3, 2013
|Story| Reuters
Original site for Cubist Pharmaceuticals Incorporated topic gallery.